Millions of people around the world live with serious diseases that cause early death and disability and place an enormous burden on healthcare systems. 在bwin中国, we are dedicated to discovering and developing new treatments for diseases including cancer, heart disease and neurological conditions - and delivering them at scale to reach as many patients as possible.

心血管

心血管疾病(CVD), which includes chronic conditions affecting the heart and blood vessels such as heart failure, 心脏病发作和中风, is the world's leading cause of death and one of society's biggest health concerns.

血液学

血液学 encompasses both malignant cancers and non-malignant disorders of the blood and blood components, such as blood cells and bone marrow cells. There are many different causes of these cancers and disorders, and prognosis can vary significantly among the different illnesses.

免疫学

免疫学 covers a broad spectrum of conditions, including chronic skin diseases such as psoriasis and hidradenitis suppurativa. 自身免疫性疾病, which form a small part of immunological diseases, 影响约4人.5% of the world’s population and their prevalence is increasing.

神经科学

Around 2 million people worldwide suffer from multiple sclerosis (MS), an autoimmune disease that is the most common cause of neurological disability unrelated to trauma in people under 40 years of age.

实体肿瘤

Cancer is the second leading cause of death worldwide. The World Health Organization (WHO) estimates there will be 50% more new cancer cases in 2040 than there are today. 在bwin中国, we’re committed to unraveling the inner workings of cancer. We’re developing new therapies for a range of common and rare cancers, investing in diverse technology platforms and experimenting with combination approaches.

相关链接

疾病

From the inception of a therapeutic through early clinical development, our disease area teams collaborate across scientific disciplines and organizations in support of our mission to improve and extend peoples lives.

bwin中国制药管道

Benefiting from our continued focus on innovation. bwin中国制药 has one of the industry's most competitive pipelines.

产品

List of the treatments we currently offer via our Innovative Medicines Division.